Scoopfeeds — Intelligent news, curated.
RFK Jr. stacks FDA panel with peptide peddlers as FDA scientists oppose access
computer-science

RFK Jr. stacks FDA panel with peptide peddlers as FDA scientists oppose access

Ars Technica · Jun 30, 2026, 6:25 PM · Also reported by 1 other source

Anti-vaccine Health Secretary Robert F. Kennedy Jr. has stacked another federal advisory panel with allies, advancing his efforts to force the Food and Drug Administration to reverse its stance on a dozen popular but unproven injectable peptide drugs. While FDA scientists determined in 2023 that the drugs lack evidence of benefits and may pose safety risks, Kennedy is a self-professed "big fan" of the dubious drugs and has vowed to "end" FDA's "aggressive suppression" of them. On Monday, the Food and Drug Administration updated its list of advisors who will review the peptides, adding nine new members—almost all of whom personally promote peptide use and/or have financial ties to wellness clinics that offer peptide treatments. The additions bring the total number of advisors to 13, making it easy for the new members to determine the outcome of upcoming meetings.Read full article Comments

Article preview — originally published by Ars Technica. Full story at the source.
Read full story on Ars Technica → More top stories

Also covered by

Aggregated and edited by the Scoop newsroom. We surface news from Ars Technica alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop